Rosetta Licenses Canadian Rights to miRNA Diagnostics to Warnex

Warnex will market the tests and send tissue samples from its customers to Rosetta's Philadelphia-based lab for analysis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.